## SDGR: Schrodinger, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 2.7% below STRENGTH zone (4.0-10.0%); PEG 1.30 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($16.28)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. BofA Securities upgrades Schrodinger stock rating to Buy from Neutral By Investing.com**
- Source: Investing.com Canada | 20251215T150926 | Bullish | Relevance: 100%
- BofA Securities has upgraded Schrodinger (NASDAQ:SDGR) from Neutral to Buy, citing the company's refocused business strategy on software operations. This shift has led to improved revenue growth and a "cleaner story" for the company, with analysts expecting benefits from the pharmaceutical R&D cycle. The upgrade follows Schrodinger's positive Q3 2025 earnings report, which surpassed EPS and revenue forecasts.

**2. B of A Securities Upgrades Schrödinger (SDGR)**
- Source: Nasdaq | 20251215T140926 | Bullish | Relevance: 100%
- B of A Securities has upgraded Schrödinger (NASDAQ:SDGR) from Neutral to Buy, with an average one-year price target of $27.77, suggesting a 53.83% upside from its current price. Institutional ownership data shows mixed activity, with some firms like Bill & Melinda Gates Foundation Trust maintaining stakes, while others like Rubric Capital Management and IJR have adjusted their holdings. The company's projected annual revenue is 505MM, a 96.71% increase, and a non-GAAP EPS of 0.05.

**3. Schrodinger (SDGR) Upgraded to Buy by B of A Securities | SDGR S**
- Source: GuruFocus | 20251215T130926 | Bullish | Relevance: 100%
- B of A Securities has upgraded Schrodinger (SDGR) from Neutral to Buy, maintaining a price target of $24.00. This upgrade comes amidst varying analyst ratings, with other firms like Keybanc and Goldman Sachs holding Overweight and Neutral ratings, respectively. Wall Street analysts project an average target price of $27.22 for SDGR, implying a potential upside of 50.82% from its current price, and GuruFocus estimates a fair value of $35.04.

**4. Schrodinger, Inc. $SDGR Shares Purchased by Nikko Asset Management Americas Inc.**
- Source: MarketBeat | 20251214T110844 | Neutral | Relevance: 100%
- Nikko Asset Management Americas Inc. increased its stake in Schrodinger, Inc. (NASDAQ:SDGR) by 7.2% in the second quarter, owning over 2.59 million shares worth $52.09 million. Other institutional investors like Rubric Capital Management LP and UBS AM also significantly boosted their holdings. The article also notes recent analyst rating changes and an insider stock sale by Margaret Dugan.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | B of A Securiti | $24 | $24 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | B of A Securiti | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.03M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 70.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Blackrock Inc.: 14.8% (-2.2%)
- Gates Foundation Tru: 10.8% (0.0%)
- Vanguard Group Inc: 9.8% (-4.2%)
- Rubric Capital Manag: 8.2% (+5.4%)
- Sumitomo Mitsui Trus: 7.1% (+24.8%)

### Key Risks

1. High short interest (25.5%, 10.0 days to cover): squeeze risk or crowded bearish bet.
2. Long-term trend broken: trading 13.9% below SMA200.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +2.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.30 suggests fair value with growth premium. Balance sheet: strong liquidity (3.2x). Revenue growth strong at 20% YoY. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1.3B |
| Beta | 1.57 |
| 52W Range | $15.99 - $28.47 |
| Short Interest | 25.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.30 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from 0.7% to 2.7% (+2.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.3pp (needs >4.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. Below SMA200 (0.86x), long-term trend not supportive. RSI neutral at 49. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.67% (CS: 67) | Neutral |
| RSI_14 | 48.6 | Neutral |
| MACD Histogram | 0.17 | Bullish |
| vs SMA20 | 1.025x | Above |
| vs SMA50 | 0.946x | Below |
| vs SMA200 | 0.861x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $17.94
- **Stop Loss:** $16.28 (9.3% risk)
- **Target:** $19.60 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 602
- **Position Value:** $10,799.88
- **Portfolio %:** 10.80%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-25 (Est: $-0.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.74 | $-0.57 | +23.0% |
| 2025Q2 | $-0.64 | $-0.65 | -1.6% |
| 2025Q1 | $-0.81 | $-0.64 | +21.0% |
| 2024Q4 | $-0.38 | $-0.24 | +36.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*